Antiphospholipid antibodies and venous thromboembolism

The Statistical Analysis of Failure Time Data.

Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875

The management of thrombosis in the antiphospholipid-antibody syndrome

Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450

The Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor Deficiencies

Proctor, R. R., & Rapaport, S. I. (1961) · American Journal of Clinical Pathology · doi:10.1093/ajcp/36.3.212 · Cited by 989

Detection of Deep-Vein Thrombosis by Real-Time B-Mode Ultrasonography

Lensing, A. W. A., Prandoni, P., Brandjes, D. P. M., Huisman, P. M., Vigo, M., Tomasella, G., Krekt, J., ten Cate, J. W., Huisman, M. V., & Buller, H. R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200602 · Cited by 868

Roentgen Diagnosis of Venous Thrombosis in the Leg

Rabinov, K. R. (1972) · Archives of Surgery · doi:10.1001/archsurg.1972.04180020014004 · Cited by 741

Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients

Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700

Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients

Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635

Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia

Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-997 · Cited by 526

Untitled work

(1963) · PubMed · Cited by 512

Antiphospholipid Antibody Syndrome: New InSights on Thrombogenic Mechanisms

Rand, J. H. (1998) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40388-x · Cited by 42

Acute pulmonary embolism

Tapson, V. F. (2004) · Cardiology Clinics · doi:10.1016/j.ccl.2004.04.002 · Cited by 42

Management of thrombosis and pregnancy loss in the antiphospholipid syndrome

Khamashta, M. A. (1998) · Lupus · doi:10.1177/096120339800700235 · Cited by 42

Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome

Ruiz‐Irastorza, G., Khamashta, M. A., & Hughes, G. R. (2001) · Lupus · doi:10.1191/096120301667789546 · Cited by 41

The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis – a population-based case-control study

Bergrem, A., Jacobsen, E., Skjeldestad, F. E., Jacobsen, A. F., Skogstad, M., & Sandset, P. M. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.12.006 · Cited by 41

Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal andheparin-treated antiphospholipid syndrome pregnancies

Donohoe, S., Quenby, S. M., Mackie, I. J., Panal, G., Farquharson, R. G., Malía, R. G., Kingdom, J. C., & Machin, S. J. (2002) · Lupus · doi:10.1191/0961203302lu132oa · Cited by 40

Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.

Brunner, H. I., Chan, W., Ginsberg, J. S., & Feldman, B. M. (2002) · PubMed · Cited by 39

Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach

Favaloro, E. J., Silvestrini, R. A., & Mohammed, A. (1999) · Pathology · doi:10.1080/003130299105331 · Cited by 39

Systemic thrombosis in patients with antiphospholipid antibodies: lesion distribution and imaging findings.

Provenzale, J. M., Ortel, T. L., & Allen, N. B. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.2.9456930 · Cited by 38

Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies?

Galtier, F., Biron, C., Vies, M., Bourgeois, V., Schved, J., & Bringer, J. (1998) · Lupus · doi:10.1191/096120398678920488 · Cited by 38

Anti-β2-Glycoprotein I Antibodies in Patients with Acute Venous Thromboembolism

Zanon, E., Prandoni, P., Vianello, F., Saggiorato, G., Carraro, G., Bagatella, P., & Girolami, A. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00105-x · Cited by 38

The Influence of Developmental Haemostasis on the Laboratory Diagnosis and Management of Haemostatic Disorders During Infancy and Childhood

Male, C., Johnston, M., Sparling, C., Brooker, L., Andrew, M. E., & Massicotte, P. M. (1999) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30128-8 · Cited by 37

HIV Infection and Antiphospholipid Antibody: Literature Review and Link to the Antiphospholipid Syndrome

Hassoun, A., Al-Kadhimi, Z. S., & Cervia, J. S. (2004) · AIDS Patient Care and STDs · doi:10.1089/1087291041444032 · Cited by 37

Ischemic Stroke in the Young

Berkman, S. A., & Song, S. S. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211002274 · Cited by 38

Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism

Kearon, C. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328356745b · Cited by 37

Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin

Wiesholzer, M., Kitzwögerer, M., Harm, F., Barbieri, G., Hauser, A.-C., Pribasnig, A., Bankl, H. C., & Balcke, P. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70222-2 · Cited by 36

Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low- density-lipoprotein antibodies in antiphospholipid syndrome

Cuadrado, M. J. (1998) · QJM · doi:10.1093/qjmed/91.9.619 · Cited by 35

LUPUS ANTICOAGULANTS AND ANTIPHOSPHOLIPID ANTIBODIES

Thiagarajan, P., & Shapiro, S. S. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70048-4 · Cited by 34

Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome

Pleguezuelo, D. E., Díaz‐Simón, R., Cabrera-Marante, Ó., Lalueza, A., Paz‐Artal, E., Lumbreras, C., & Hernández, A. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667515 · Cited by 33

The Clinical Significance of Antiphospholipid Antibodies

Martini, A., & Ravelli, A. (1997) · Annals of Medicine · doi:10.3109/07853899709113704 · Cited by 33

Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients

Nojima, J., Masuda, Y., Iwatani, Y., Suehisa, E., Futsukaichi, Y., Kuratsune, H., Watanabe, Y., Takano, T., Hidaka, Y., & Kanakura, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.173 · Cited by 32

Antiphospholipid antibiodies: a critical review of the literature

Lim, W., & Crowther, M. A. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282a4a65f · Cited by 32

Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.

Valle, P. D., Crippa, L., Garlando, A. M., Pattarini, E., Safa, O., D’Angelo, S., & D’Angelo, A. (1999) · PubMed · Cited by 31

Treatment and prophylaxis of venous thromboembolism during pregnancy

Bates, S. M. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00399-7 · Cited by 30

Clinical and laboratory evaluation of thrombophilia

Perry, S. L., & Ortel, T. L. (2003) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(02)00054-0 · Cited by 30

Disease modifying treatment and elective surgery in rheumatoid arthritis: the need for more data

Jain, A., Maini, R., & Nanchahal, J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.017640 · Cited by 30

Arteriosclerosis obliterans associated with anti-cardiolipin antibody / 2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus

Nojima, J., Masuda, Y., Iwatani, Y., Kuratsune, H., Watanabe, Y., Suehisa, E., Takano, T., Hidaka, Y., & Kanakura, Y. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken124 · Cited by 29

Pathology Consultation on Anticoagulation Monitoring

Wool, G. D., & Lu, C. M. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpr3jtok7nkdbj · Cited by 28

The role of anti-phospholipid antibodies in autoimmune reproductive failure

Pantham, P., Abrahams, V. M., & Chamley, L. (2016) · Reproduction · doi:10.1530/rep-15-0545 · Cited by 28

Prevalence of Anticardiolipin Antibodies in Peripheral Arterial Thrombosis

de Godoy, M. F., Braile, D. M., Torres, C. A. A., & de Godoy, J. M. P. (2000) · Angiology · doi:10.1177/000331970005100604 · Cited by 28

The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus

Crowther, M., Julian, J., Stewart, K., Donovan, D., Kaminska, E., Laskin, C., Ginsberg, J., & Douketis, J. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614324 · Cited by 27

Anticoagulating patients with high-risk acquired thrombophilias

Skeith, L. (2018) · Blood · doi:10.1182/blood-2018-05-848697 · Cited by 26

Recomendaciones de la Sociedad Española de Reumatología sobre síndrome antifosfolípido primario. Parte I: Diagnóstico, evaluación y tratamiento

Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Carmona, L., et al. (2019) · Reumatología Clínica · doi:10.1016/j.reuma.2018.11.003 · Cited by 26

Study of clinical, radiological and echocardiographic features and correlation of Qanadli CT index with RV dysfunction and outcomes in pulmonary embolism

Kumar, B. S., Rajasekhar, D., & Vanajakshamma, V. (2014) · Indian Heart Journal · doi:10.1016/j.ihj.2014.10.405 · Cited by 26

Role of platelet factor 4–heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis

Nakamoto, H., Shimada, Y., Kanno, T., Wanaka, K., Matsuo, T., & Suzuki, H. (2005) · Hemodialysis International · doi:10.1111/j.1542-4758.2005.01163.x · Cited by 26

Optimal Duration of Oral Anticoagulant Therapy in Venous Thromboembolism

Schulman, S. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657614 · Cited by 26

Peri-operative management of ophthalmic patients taking antithrombotic therapy

Lip, G. Y. H., Durrani, O. M., Roldán, V., Lip, P. L., Marín, F. R., & Reuser, T. Q. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02538.x · Cited by 25

How I manage venous thromboembolism risk in hospitalized medical patients

Dobromirski, M., & Cohen, A. T. (2012) · Blood · doi:10.1182/blood-2012-03-378901 · Cited by 26

Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells

Motoki, Y., Nojima, J., Yanagihara, M., Tsuneoka, H., Matsui, T., Yamamoto, M., & Ichihara, K. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.11.048 · Cited by 25

The anti-phospholipid antibody syndrome (Hughes syndrome): therapeutic aspects

Cuadrado, M. J., & Khamashta, M. A. (2000) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.1999.0083 · Cited by 25

Which Antiphospholipid Antibodies Should Be Measured in the Antiphospholipid Syndrome?

Galli, M. (2000) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000054164 · Cited by 25

Autoimmune disease as a cause of reproductive failure

Rote, N. S., & Stetzer, B. P. (2003) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(03)00022-2 · Cited by 26

High prevalence of anti‐prothrombin antibody in patients with deep vein thrombosis

Ishikura, K., Wada, H., Kamikura, Y., Hattori, K., Fukuzawa, T., Yamada, N., Nakamura, M., Nobori, T., & Nakano, T. (2004) · American Journal of Hematology · doi:10.1002/ajh.20124 · Cited by 25

Laboratory Testing for Heparin-Induced Thrombocytopenia

Warkentin, T. E., & Greinacher, A. (2007) · Fundamental and clinical cardiology · doi:10.3109/9781420045093.010 · Cited by 24

Thrombophilia as a common predisposing factor in pseudotumor cerebri

Dunkley, S. M., & Johnston, I. (2004) · Blood · doi:10.1182/blood-2003-09-3017 · Cited by 24

Clinical Importance of Positive Test Results for Lupus Anticoagulant and Anticardiolipin Antibodies

Prøven, A., Bartlett, R. P., Moder, K. G., Chang‐Miller, A., Cardel, L. K., Heit, J. A., Homburger, H. A., Petterson, T. M., Christianson, T. J. H., & Nichols, W. L. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.4.467 · Cited by 23

The treatment of antiphospholipid syndrome: A harmonic contrast

Ruiz‐Irastorza, G., & Khamashta, M. A. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.10.003 · Cited by 23

Loss of antiphospholipid antibody positivity post-thrombosis in SLE

Khawaja, M., Magder, L. S., GOLDMAN, D. W., & Petri, M. (2020) · Lupus Science & Medicine · doi:10.1136/lupus-2020-000423 · Cited by 22

Controversies in the antiphospholipid syndrome: can we ever stop warfarin?

Fonseca, A. G., & D’Cruz, D. P. (2008) · Journal of Autoimmune Diseases · doi:10.1186/1740-2557-5-6 · Cited by 23

Usefulness of glycosylated ferritin in atypical presentations of adult onset Still's disease

Hamidou, M. A., Denis, M., Barbarot, S., Boutoille, D., Belizna, C. C., & Moël, G. L. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012484 · Cited by 22

Changes of the soluble fibrin monomer complex level during the perioperative period of hip replacement surgery

Tomonori, M., Kitajima, I., Kabata, T., Tani, M., Kabata, C., Tsubokawa, T., Asakura, H., & Tomita, K. (2008) · Journal of Orthopaedic Science · doi:10.1007/s00776-008-1266-y · Cited by 21

3 Acquired thrombophilia

Girling, J., & de Swiet, M. (1997) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(97)80021-1 · Cited by 21

Recurrent Thrombosis in Patients with Deep Vein Thrombosis and/or Venous Thromboembolism Associated with Anticardiolipin Antibodies

de Godoy, J. M. P., de Godoy, M. F., & Braile, D. M. (2006) · Angiology · doi:10.1177/000331970605700111 · Cited by 23

Management of Antiphospholipid Antibody Syndrome

Lim, W., & Crowther, M. A. (2008) · Wiley eBooks · doi:10.1002/9781444300857.ch21 · Cited by 21

Antiphospholipid Syndrome: General Features

Godfrey, T., & D’Cruz, D. P. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_2 · Cited by 21

Transient lupus anticoagulant: an unusual cause of bruising in children

Anderson, A.-K., Mohan, U., & Liesner, R. J. (2003) · Emergency Medicine Journal · doi:10.1136/emj.20.5.e6 · Cited by 20

Use of warfarin therapy at a target international normalized ratio of 3.0 for cutaneous polyarteritis nodosa

Kawakami, T., & Soma, Y. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.10.033 · Cited by 20

Mechanism of action of β2-glycoprotein I-dependent lupus anticoagulants

Amout, J., & Vermylen, J. (1998) · Lupus · doi:10.1177/096120339800700206 · Cited by 20

Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy☆

D’Armini, A. M., Totaro, P., Nicolardi, S., Morsolini, M., Silvaggio, G., Toscano, F., Toscano, M., & Viganò, M. (2009) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2009.221630 · Cited by 19

Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis

Palomo, I. F., Pereira, J. I., Alarcón, M. A., V�squez, M., Pinochet, C., V�lez, M. T., Sandoval, J. I., Icaza, G., & Pierangeli, S. S. (2004) · Clinical Rheumatology · doi:10.1007/s10067-003-0846-7 · Cited by 19

The pathogenic role of annexin-V in the antiphospholipid syndrome

Rand, J. H. (2000) · Current Rheumatology Reports · doi:10.1007/s11926-000-0086-7 · Cited by 19

Do we Know which Patients with the Antiphospholipid Syndrome Should Receive Long-term High Dose Anti-coagulation?

Derksen, R. H. W. M., & de Groot, P. G. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0395 · Cited by 19

Pseudo–Heparin-Induced Thrombocytopenia

(2003) · Informa Healthcare eBooks · doi:10.1201/9780203027363.ch12 · Cited by 19

Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia

Öztürk, M. A., Haznedaroğlu, İ. C., Turgut, M., & Göker, H. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000201 · Cited by 19

The natural history of venous thromboembolism: Impact on ventilation/perfusion scan reporting

Gray, H. W. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.124176 · Cited by 18

Early diagnosis of deep vein thrombosis in female patients who undergo total knee arthroplasty with measurement of P-selectin activation

Yang, L.-C., Wang, C., Lee, T.-H., Lin, F.-C., Yang, B.-Y., Lin, C., & Lee, T.-C. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.121852 · Cited by 18

Evaluation of the hypercoagulable state

Barger, A. P., & Hurley, R. (2000) · Postgraduate Medicine · doi:10.3810/pgm.2000.09.15.1236 · Cited by 18

Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis

Sidelmann, J. J., Sjøland, J. A., Gram, J., Bertelsen, V., Mourits‐Andersen, T., Münster, H., Münster, A. B., & Jespersen, J. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601038992 · Cited by 20

Antiphospholipid antibody associated thrombosis: A consensus for treatment?

McCrae, K. (1996) · Lupus · doi:10.1177/096120339600500602 · Cited by 18

Influence of lipid metabolism disorders on venous thrombosis risk

Spasić, I., Ubavic, M., Šumarac, Z., Todorović, M., & Vučković, B. (2021) · Journal of Medical Biochemistry · doi:10.5937/jomb0-27106 · Cited by 17

Thromboprophylaxis and obstetric management of the antiphospholipid syndrome

Espinosa, G., & Cervera, R. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902772302 · Cited by 16

Management of Thrombosis in Women With Antiphospholipid Syndrome

Chandramouli, N. B., & Rodgers, G. M. (2001) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200103000-00006 · Cited by 17

Survey of Factor V Leiden and Prothrombin Gene Mutations in Systemic Lupus Erythematosus

Topaloğlu, R., Akıerli, C., Bakkaloğlu, A., Aydıntuğ, O., Özen, S., Beşbaş, N., & Özçelık, T. (2001) · Clinical Rheumatology · doi:10.1007/s100670170040 · Cited by 17

Pseudo-Heparin-Induced Thrombocytopenia

Warkentin, T. E. (2007) · Fundamental and clinical cardiology · doi:10.3109/9781420045093.011 · Cited by 17

Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome

Efthymiou, M., Gates, C., Isenberg, D. A., & Cohen, H. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0036-1597902 · Cited by 16

Monitoring Therapy with Vitamin K Antagonists in Patients with Lupus Anticoagulant: Effect on Different Tests for INR Determination

Bijsterveld, N. R., Middeldorp, S., Berends, F., & Buller, H. R. (2000) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1018722829498 · Cited by 16

Acquired thrombophilic syndromes

Matei, D. E., Brenner, B., & Marder, V. J. (2001) · Blood Reviews · doi:10.1054/blre.2001.0148 · Cited by 16

Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome

Küçükkaya, R. D., Hançer, V. S., İnanç, M., Nalçacı, M., & Pekçelen, Y. (2004) · Lupus · doi:10.1191/0961203304lu479oa · Cited by 16

Hypercoagulability and venous thromboembolism: a review.

Mazza, J. J. (2004) · PubMed · Cited by 15

Hypercoagulable state testing and malignancy screening following venous thromboembolic events

Deitcher, S. R., & Gomes, M. P. V.-F. (2003) · Vascular Medicine · doi:10.1191/1358863x03vm461ra · Cited by 16

Clinical aspects of pulmonary embolism

Hampson, N. B., & Culver, B. H. (1997) · Seminars in Ultrasound CT and MRI · doi:10.1016/s0887-2171(97)90009-3 · Cited by 15

Traveller's venous thromboembolism

Parsi, K. (2001) · Cardiovascular Surgery · doi:10.1016/s0967-2109(00)00116-2 · Cited by 14

Platelet and endothelial activation are requisites for the development of antiphospholipid syndrome

Garcia, E. D. R., Rodriguez, C. S., Rodríguez-Martorell, J., Serrano, A., & González, J. A. G. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.010694 · Cited by 14

Le syndrome des antiphospholipides

Arvieux, J., & HACHULLA, E. (2002) · Annales de Cardiologie et d Angéiologie · doi:10.1016/s0003-3928(02)00087-2 · Cited by 14

The epidemiology of the antiphospholipid syndrome: Who is at risk?

Finazzi, G. (2001) · Current Rheumatology Reports · doi:10.1007/s11926-001-0030-5 · Cited by 14

Optimisation de l’interrogatoire dans l’évaluation du risque de maladie thromboembolique veineuse : l’étude OPTIMEV

Sevestre, M., Labarère, J., Brin, S., Carpentier, P., Constans, J., Degeilh, M., Deslandes, B., Elgrishi, I., Lanoye, P., Laroche, J.-P., et al. (2005) · Journal des Maladies Vasculaires · doi:10.1016/s0398-0499(05)88206-x · Cited by 13

Antiphospholipid Antibody Syndrome: Current Concepts

Goel, N. (1998) · Hospital Practice · doi:10.1080/21548331.1998.11443641 · Cited by 14

Prevalence of thrombophilia associated with leg ulcers

Brandt, H. R. C., Messina, M. C. D. L., Hirayama, J., Belda, W., Benabou, J. E., & Criado, P. R. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08894.x · Cited by 13

Venous thromboembolism

Tk, D., & Venugopal, V. (2009) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.48442 · Cited by 13

How much warfarin is enough in APS related thrombosis?

Erkan, D., & Lockshin, M. D. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.010 · Cited by 13

Anti β2-glycoprotein I antibodies: Clinical significance

Tincani, A., Spatola, L., Cinquini, M., Cattaneo, R., Meroni, P. L., & Balestrieri, G. (1998) · Lupus · doi:10.1177/096120339800700224 · Cited by 13

Thrombophilia testing has limited usefulness in clinical decision-making and should be used selectively

Masuda, E. M., Lee, R. W., Okazaki, I. J., Benyamini, P., & Kistner, R. L. (2015) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2015.01.001 · Cited by 12

Laboratory Evaluation of Patients with Systemic Lupus Erythematosus

Schur, P. H. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10034-8 · Cited by 12

The antiphospholipid syndrome

Franchini, M., & Veneri, D. (2005) · Hematology · doi:10.1080/10245330500141309 · Cited by 12

Comparative prevalence of antiphospholipid antibodies and thrombophilic genotypes in consecutive patients with venous thrombosis

Cappucci, G., Margaglione, M., & Ames, P. R. J. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200112000-00007 · Cited by 12

Tratamiento de la enfermedad tromboembólica venosa

Rocha, E. A. V., Panizo, C., & Lecumberri, R. (2000) · Medicina Clínica · doi:10.1016/s0025-7753(00)71516-8 · Cited by 12

Warfarin in antiphospholipid syndrome--time to explore new horizons.

Erkan, D., Ortel, T. L., & Lockshin, M. D. (2005) · PubMed · Cited by 12

Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation

Miesbach, W., Scharrer, I., & Asherson, R. A. (2004) · Clinical Rheumatology · doi:10.1007/s10067-004-0864-0 · Cited by 11

Treatment of thrombotic antiphospholipid syndrome in adults and children

Madison, J. A., Duarte‐García, A., Zuo, Y., & Knight, J. S. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000702 · Cited by 12

The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

da Rosa, G. P., Sousa‐Pinto, B., Ferreira, E., Araújo, O., Barilaro, G., Bettencourt, P., Cervera, R., & Espinosa, G. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02702-9 · Cited by 11

Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis

Wahl, D. G., Guillemin, F., de Maistre, E., Perret‐Guillaume, C., Lecompte, T., & Thibaut, G. (1998) · Lupus · doi:10.1191/096120398678919688 · Cited by 184

Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review

Garcia, D. A., Akl, E. A., Carr, R., & Kearon, C. (2013) · Blood · doi:10.1182/blood-2013-04-496257 · Cited by 135

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis

Wahl, D., Guillemin, F., de Maistre, E., Perret, C., Lecompte, T., & Thibaut, G. (1997) · Lupus · doi:10.1177/096120339700600510 · Cited by 285

Prevalence of antiphospholipid antibodies in an Australian cohort of patients with unprovoked venous thromboembolism

Ho, W. K., & Rigano, J. (2018) · Pathology · doi:10.1016/j.pathol.2017.12.344 · Cited by 4

Antiphospholipid Syndrome in Patients with Venous Thromboembolism

Pengo, V., & Denas, G. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1749590 · Cited by 8